CAPTRUST Financial Advisors
HAE icon

CAPTRUST Financial Advisors’s Haemonetics HAE Stock Holding History

CAPTRUST Financial Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438K Buy
5,838
+149
+3% +$9.57K ﹤0.01% 2278
2026
Q1 		$321K Sell
5,689
-446
-7% -$29K ﹤0.01% 2342
2025
Q4 		$492K Buy
6,135
+1,820
+42% +$122K ﹤0.01% 1911
2025
Q3 		$210K Sell
4,315
-6,706
-61% -$415K ﹤0.01% 2393
2025
Q2 		$822K Buy
11,021
+6,660
+153% +$441K ﹤0.01% 1452
2025
Q1 		$277K Sell
4,361
-511
-10% -$34.8K ﹤0.01% 1984
2024
Q4 		$380K Buy
4,872
+624
+15% +$50.1K ﹤0.01% 1767
2024
Q3 		$341K Buy
4,248
+982
+30% +$79.3K ﹤0.01% 1811
2024
Q2 		$270K Buy
3,266
+62
+2% +$5.45K ﹤0.01% 1871
2024
Q1 		$273K Sell
3,204
-3,353
-51% -$263K ﹤0.01% 1827
2023
Q4 		$561K Sell
6,557
-4,265
-39% -$369K ﹤0.01% 1662
2023
Q3 		$969K Buy
10,822
+1,865
+21% +$167K ﹤0.01% 1227
2023
Q2 		$763K Buy
+8,957
New +$757K ﹤0.01% 1375
2022
Q3 		– Sell
-2,250
Closed -$147K – 2908
2022
Q2 		$147K Sell
2,250
-85
-4% -$5.03K ﹤0.01% 1914
2022
Q1 		$148K Buy
2,335
+585
+33% +$31.8K ﹤0.01% 1948
2021
Q4 		$93K Sell
1,750
-405
-19% -$24.7K ﹤0.01% 2216
2021
Q3 		$152K Buy
2,155
+105
+5% +$6.63K ﹤0.01% 1747
2021
Q2 		$137K Buy
2,050
+40
+2% +$2.83K ﹤0.01% 1785
2021
Q1 		$223K Buy
2,010
+1,875
+1,389% +$232K ﹤0.01% 1400
2020
Q4 		$16K Hold
135
– – ﹤0.01% 2357
2020
Q3 		$12K Buy
135
+110
+440% +$9.61K ﹤0.01% 2204
2020
Q2 		$2K Buy
+25
New +$2.52K ﹤0.01% 2603
2019
Q4 		– Sell
-25
Closed -$3K – 1341
2019
Q3 		$3K Hold
25
– – ﹤0.01% 1736
2019
Q2 		$3K Buy
+25
New +$2.46K ﹤0.01% 1742

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAPTRUST Financial Advisors's HAE Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Haemonetics (HAE) stake by 2.6% in Q2 2026, buying an estimated $9.57K and bringing the position to 5,838 shares worth $438K. The position accounts for ﹤0.01% of the portfolio, ranked #2278.

CAPTRUST Financial Advisors first reported a position in HAE in Q2 2019 and has held it in 24 quarters since. The position peaked at $969K in Q3 2023. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • CAPTRUST Financial Advisors held 5,838 shares of Haemonetics worth $438K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 149 Haemonetics shares in Q2 2026, an estimated $9.57K.
  • Haemonetics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2278 holding.
  • CAPTRUST Financial Advisors first reported a position in Haemonetics in Q2 2019 and has held it in 24 quarters since.
  • CAPTRUST Financial Advisors's Haemonetics position peaked at $969K in Q3 2023.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.